Teva Pharmaceutical Industries Ltd. (TEVA.TV, TEVA), which launched a $40 billion bid for Mylan NV (MYL) in April, plans to increase the value of its offer, Bloomberg News reported Monday, citing people with knowledge of the matter.

Teva's offer is worth $82 a share. Bloomberg reported that a new bid may be worth $86 to $88 a share.

The new offer could be announced this week, Bloomberg reported.

Full story at http://www.bloomberg.com/news/articles/2015-07-06/teva-said-planning-to-raise-mylan-bid-to-86-88-share-this-week

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Teva Pharmaceutical Indu... Charts.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Teva Pharmaceutical Indu... Charts.